Opening book details…
Can I read Drugs and the Pharmaceutical Sciences V.201 : Generic Drug Product Development : International Regulatory Requirements for Bioequivalence on EtoBox?
Drugs and the Pharmaceutical Sciences V.201 : Generic Drug Product Development : International Regulatory Requirements for Bioequivalence by Isadore Kanfer (ed.), Leon Shargel (ed.) is a nonfiction available to read on EtoBox.
What is Drugs and the Pharmaceutical Sciences V.201 : Generic Drug Product Development : International Regulatory Requirements for Bioequivalence about?
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.
Who reads Drugs and the Pharmaceutical Sciences V.201 : Generic Drug Product Development : International Regulatory Requirements for Bioequivalence?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Isadore Kanfer (ed.), Leon Shargel (ed.)
- Publisher
- Informa Healthcare USA
- Published
- 2010
- Language
- EN
- ISBN
- 9780849377853
- Category
- nonfiction
- Subjects
- Science, Technology, Chemistry
More by Isadore Kanfer (ed.), Leon Shargel (ed.)
Browse all works by Isadore Kanfer (ed.), Leon Shargel (ed.)
Similar books
- Generic Drug Product Development: Bioequivalence Issues (Drugs and the Pharmaceutical Sciences, 180) — Isadore Kanfer; Leon Shargel (2007)
- Drugs and the Pharmaceutical Sciences V.216 : Biosimilar Drug Product Development — Laszlo Endrenyi, Dr. Paul Declerck, Shein-Chung Chow (2017)
- Drug Interactions (Drugs and the Pharmaceutical Sciences) — edited by A. David Rodrigues (2001)
- Supercritical Fluid Technology for Drug Product Development (Drugs and the Pharmaceutical Sciences) (Vol 138) — edited by Peter York, Uday B. Kompella, Boris Y. Shekunov.,M. Dekker (2004)
- Preclinical Drug Development (Drugs and the Pharmaceutical Sciences Book 152) — edited by Mark C. Rogge, David R. Taft (2005)
- Herbal Supplements-Drug Interactions: Scientific and Regulatory Perspectives (Drugs and the Pharmaceutical Sciences Book 162) — edited by Y.W. Francis Lam, Shiew-Mei Huang, Stephen D. Hall (2006)